ArticleInfection & chemotherapy2018

Effectiveness, Safety, and Tolerability of a Switch to Dual Therapy with Dolutegravir Plus Cobicistat-Boosted Darunavir in Treatment-Experienced Patients with Human Immunodeficiency Virus.

Sang Ah Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.